2023-2029 Global Prophylactic Gamma Globulin Industry Research & Trends Analysis Report
According to Latest Study, the global market for Prophylactic Gamma Globulin should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Prophylactic Gamma Globulin market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Prophylactic Gamma Globulin market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, IVIg Liquid segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Immunodeficiency has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Prophylactic Gamma Globulin include Baxter, Grifols, Octapharma, Biotest, Kedrion Biopharma, Takeda, ADMA Biologics, BPL and LFB Group, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
The gamma globulin fraction of pooled normal human sera has a wide range of usefulness in the prophylaxis of many infectious diseases. Hyperimmune human globulin preparations are effective against certain other illnesses in which globulins pooled from normal sera contain insufficient antibody.
This report aims to provide a comprehensive study of the global market for Prophylactic Gamma Globulin. Report Highlights:
(1) Global Prophylactic Gamma Globulin market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Prophylactic Gamma Globulin market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Prophylactic Gamma Globulin market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Prophylactic Gamma Globulin segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Prophylactic Gamma Globulin segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Prophylactic Gamma Globulin, capacity, production and trends.
(7) Prophylactic Gamma Globulin industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
IVIg Liquid
IVIg Powder
Market segment by application, can be divided into
Immunodeficiency
Autoimmune Disease
Acute Infection
Market segment by players, this report covers
Baxter
Grifols
Octapharma
Biotest
Kedrion Biopharma
Takeda
ADMA Biologics
BPL
LFB Group
Hualan Biological
Beijing Tiantan Biological
Beijing Bohui Innovation Biotechnology
Pacific Shuanglin Bio-pharmacy
Shenzhen Weiguang Biological
CBPO
CNBG
Shanghai RAAS
Sichuan Yuanda Shuyang
1 Market Overview
1.1 Prophylactic Gamma Globulin Definition
1.2 Global Prophylactic Gamma Globulin Market Size and Forecast
1.2.1 By Revenue, Global Prophylactic Gamma Globulin Market Size, 2018-2029
1.2.2 By Sales Volume, Global Prophylactic Gamma Globulin Market Size, 2018-2029
1.2.3 Global Prophylactic Gamma Globulin Price Trend, 2018-2029
1.3 China Prophylactic Gamma Globulin Market Size and Forecast
1.3.1 By Revenue, China Prophylactic Gamma Globulin Market Size, 2018-2029
1.3.2 By Sales Volume, China Prophylactic Gamma Globulin Market Size, 2018-2029
1.3.3 China Prophylactic Gamma Globulin Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Prophylactic Gamma Globulin Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Prophylactic Gamma Globulin Share in Global Market, 2018-2029
1.4.3 Prophylactic Gamma Globulin Market Size: China VS Global, 2018-2029
1.5 Prophylactic Gamma Globulin Market Dynamics
1.5.1 Prophylactic Gamma Globulin Market Drivers
1.5.2 Prophylactic Gamma Globulin Market Restraints
1.5.3 Prophylactic Gamma Globulin Industry Trends
1.5.4 Prophylactic Gamma Globulin Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Prophylactic Gamma Globulin Revenue by Company, 2018-2023
2.2 Global Prophylactic Gamma Globulin Sales Volume by Company, 2018-2023
2.3 Global Prophylactic Gamma Globulin Price by Company, 2018-2023
2.4 Global Prophylactic Gamma Globulin Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Prophylactic Gamma Globulin Concentration Ratio
2.6 Global Prophylactic Gamma Globulin Mergers & Acquisitions, Expansion Plans
2.7 Global Prophylactic Gamma Globulin Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Prophylactic Gamma Globulin Revenue by Company, 2018-2023
3.2 China Prophylactic Gamma Globulin Sales Volume by Company, 2018-2023
3.3 China Prophylactic Gamma Globulin Prophylactic Gamma Globulin Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Prophylactic Gamma Globulin Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Prophylactic Gamma Globulin Domestic VS Export
3.6 China Market, Prophylactic Gamma Globulin Import & Export
3.6.1 China Market, Prophylactic Gamma Globulin Import & Export, 2018-2029
3.6.2 China Prophylactic Gamma Globulin Import & Export Trends
3.6.3 Main Sources of China Prophylactic Gamma Globulin Import
3.6.4 Export Destination of China Prophylactic Gamma Globulin
4 Prophylactic Gamma Globulin Production by Region
4.1 Global Prophylactic Gamma Globulin Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Prophylactic Gamma Globulin Manufacturers
4.3 Global Major Manufacturers, Prophylactic Gamma Globulin Capacity Expansion and Future Plans
4.4 Global Prophylactic Gamma Globulin Capacity by Region
4.5 Global Prophylactic Gamma Globulin Production by Region
4.5.1 Global Prophylactic Gamma Globulin Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Prophylactic Gamma Globulin Production by Region, 2018-2023
4.5.3 Global Prophylactic Gamma Globulin Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Prophylactic Gamma Globulin Industry Chain
5.2 Prophylactic Gamma Globulin Upstream Analysis
5.2.1 Prophylactic Gamma Globulin Core Raw Materials
5.2.2 Main Manufacturers of Prophylactic Gamma Globulin Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Prophylactic Gamma Globulin Production Mode
5.6 Prophylactic Gamma Globulin Procurement Model
5.7 Prophylactic Gamma Globulin Industry Sales Model and Sales Channels
5.7.1 Prophylactic Gamma Globulin Sales Model
5.7.2 Prophylactic Gamma Globulin Typical Distributors
6 Sights by Type
6.1 Prophylactic Gamma Globulin Classification
6.1.1 IVIg Liquid
6.1.2 IVIg Powder
6.2 By Type, Global Prophylactic Gamma Globulin Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Prophylactic Gamma Globulin Revenue, 2018-2029
6.4 By Type, Global Prophylactic Gamma Globulin Sales Volume, 2018-2029
6.5 By Type, Global Prophylactic Gamma Globulin Price, 2018-2029
7 Sights by Application
7.1 Prophylactic Gamma Globulin Segment by Application
7.1.1 Immunodeficiency
7.1.2 Autoimmune Disease
7.1.3 Acute Infection
7.2 By Application, Global Prophylactic Gamma Globulin Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Prophylactic Gamma Globulin Revenue, 2018-2029
7.4 By Application, Global Prophylactic Gamma Globulin Sales Volume, 2018-2029
7.5 By Application, Global Prophylactic Gamma Globulin Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Prophylactic Gamma Globulin Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Prophylactic Gamma Globulin Revenue, 2018-2029
8.3 By Region, Global Prophylactic Gamma Globulin Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Prophylactic Gamma Globulin Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Prophylactic Gamma Globulin Market Size Market Share
8.5 Europe
8.5.1 Europe Prophylactic Gamma Globulin Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Prophylactic Gamma Globulin Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Prophylactic Gamma Globulin Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Prophylactic Gamma Globulin Market Size Market Share
8.7 South America
8.7.1 South America Prophylactic Gamma Globulin Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Prophylactic Gamma Globulin Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Prophylactic Gamma Globulin Market Size & CAGR，2018 VS 2022 VS 2029
9.2 By Country, Global Prophylactic Gamma Globulin Revenue, 2018-2029
9.3 By Country, Global Prophylactic Gamma Globulin Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Prophylactic Gamma Globulin Market Size, 2018-2029
9.4.2 By Company, U.S. Prophylactic Gamma Globulin Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Prophylactic Gamma Globulin Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Prophylactic Gamma Globulin Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Prophylactic Gamma Globulin Market Size, 2018-2029
9.5.2 By Company, Europe Prophylactic Gamma Globulin Sales Volume Market Share, 2022
9.5.3 By Type, Europe Prophylactic Gamma Globulin Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Prophylactic Gamma Globulin Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Prophylactic Gamma Globulin Market Size, 2018-2029
9.6.2 By Company, China Prophylactic Gamma Globulin Sales Volume Market Share, 2022
9.6.3 By Type, China Prophylactic Gamma Globulin Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Prophylactic Gamma Globulin Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Prophylactic Gamma Globulin Market Size, 2018-2029
9.7.2 By Company, Japan Prophylactic Gamma Globulin Sales Volume Market Share, 2022
9.7.3 By Type, Japan Prophylactic Gamma Globulin Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Prophylactic Gamma Globulin Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Prophylactic Gamma Globulin Market Size, 2018-2029
9.8.2 By Company, South Korea Prophylactic Gamma Globulin Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Prophylactic Gamma Globulin Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Prophylactic Gamma Globulin Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Prophylactic Gamma Globulin Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Prophylactic Gamma Globulin Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Prophylactic Gamma Globulin Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Prophylactic Gamma Globulin Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Prophylactic Gamma Globulin Market Size, 2018-2029
9.10.2 By Company, India Prophylactic Gamma Globulin Sales Volume Market Share, 2022
9.10.3 By Type, India Prophylactic Gamma Globulin Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Prophylactic Gamma Globulin Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Prophylactic Gamma Globulin Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Prophylactic Gamma Globulin Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Prophylactic Gamma Globulin Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Prophylactic Gamma Globulin Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Baxter
10.1.1 Baxter Company Information, Head Office, Market Area and Industry Position
10.1.2 Baxter Prophylactic Gamma Globulin Models, Specifications and Application
10.1.3 Baxter Prophylactic Gamma Globulin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Baxter Company Profile and Main Business
10.1.5 Baxter Recent Developments
10.2 Grifols
10.2.1 Grifols Company Information, Head Office, Market Area and Industry Position
10.2.2 Grifols Prophylactic Gamma Globulin Models, Specifications and Application
10.2.3 Grifols Prophylactic Gamma Globulin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Grifols Company Profile and Main Business
10.2.5 Grifols Recent Developments
10.3 Octapharma
10.3.1 Octapharma Company Information, Head Office, Market Area and Industry Position
10.3.2 Octapharma Prophylactic Gamma Globulin Models, Specifications and Application
10.3.3 Octapharma Prophylactic Gamma Globulin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Octapharma Company Profile and Main Business
10.3.5 Octapharma Recent Developments
10.4 Biotest
10.4.1 Biotest Company Information, Head Office, Market Area and Industry Position
10.4.2 Biotest Prophylactic Gamma Globulin Models, Specifications and Application
10.4.3 Biotest Prophylactic Gamma Globulin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Biotest Company Profile and Main Business
10.4.5 Biotest Recent Developments
10.5 Kedrion Biopharma
10.5.1 Kedrion Biopharma Company Information, Head Office, Market Area and Industry Position
10.5.2 Kedrion Biopharma Prophylactic Gamma Globulin Models, Specifications and Application
10.5.3 Kedrion Biopharma Prophylactic Gamma Globulin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Kedrion Biopharma Company Profile and Main Business
10.5.5 Kedrion Biopharma Recent Developments
10.6 Takeda
10.6.1 Takeda Company Information, Head Office, Market Area and Industry Position
10.6.2 Takeda Prophylactic Gamma Globulin Models, Specifications and Application
10.6.3 Takeda Prophylactic Gamma Globulin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Takeda Company Profile and Main Business
10.6.5 Takeda Recent Developments
10.7 ADMA Biologics
10.7.1 ADMA Biologics Company Information, Head Office, Market Area and Industry Position
10.7.2 ADMA Biologics Prophylactic Gamma Globulin Models, Specifications and Application
10.7.3 ADMA Biologics Prophylactic Gamma Globulin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 ADMA Biologics Company Profile and Main Business
10.7.5 ADMA Biologics Recent Developments
10.8 BPL
10.8.1 BPL Company Information, Head Office, Market Area and Industry Position
10.8.2 BPL Prophylactic Gamma Globulin Models, Specifications and Application
10.8.3 BPL Prophylactic Gamma Globulin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 BPL Company Profile and Main Business
10.8.5 BPL Recent Developments
10.9 LFB Group
10.9.1 LFB Group Company Information, Head Office, Market Area and Industry Position
10.9.2 LFB Group Prophylactic Gamma Globulin Models, Specifications and Application
10.9.3 LFB Group Prophylactic Gamma Globulin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 LFB Group Company Profile and Main Business
10.9.5 LFB Group Recent Developments
10.10 Hualan Biological
10.10.1 Hualan Biological Company Information, Head Office, Market Area and Industry Position
10.10.2 Hualan Biological Prophylactic Gamma Globulin Models, Specifications and Application
10.10.3 Hualan Biological Prophylactic Gamma Globulin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Hualan Biological Company Profile and Main Business
10.10.5 Hualan Biological Recent Developments
10.11 Beijing Tiantan Biological
10.11.1 Beijing Tiantan Biological Company Information, Head Office, Market Area and Industry Position
10.11.2 Beijing Tiantan Biological Prophylactic Gamma Globulin Models, Specifications and Application
10.11.3 Beijing Tiantan Biological Prophylactic Gamma Globulin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Beijing Tiantan Biological Company Profile and Main Business
10.11.5 Beijing Tiantan Biological Recent Developments
10.12 Beijing Bohui Innovation Biotechnology
10.12.1 Beijing Bohui Innovation Biotechnology Company Information, Head Office, Market Area and Industry Position
10.12.2 Beijing Bohui Innovation Biotechnology Prophylactic Gamma Globulin Models, Specifications and Application
10.12.3 Beijing Bohui Innovation Biotechnology Prophylactic Gamma Globulin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Beijing Bohui Innovation Biotechnology Company Profile and Main Business
10.12.5 Beijing Bohui Innovation Biotechnology Recent Developments
10.13 Pacific Shuanglin Bio-pharmacy
10.13.1 Pacific Shuanglin Bio-pharmacy Company Information, Head Office, Market Area and Industry Position
10.13.2 Pacific Shuanglin Bio-pharmacy Prophylactic Gamma Globulin Models, Specifications and Application
10.13.3 Pacific Shuanglin Bio-pharmacy Prophylactic Gamma Globulin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Pacific Shuanglin Bio-pharmacy Company Profile and Main Business
10.13.5 Pacific Shuanglin Bio-pharmacy Recent Developments
10.14 Shenzhen Weiguang Biological
10.14.1 Shenzhen Weiguang Biological Company Information, Head Office, Market Area and Industry Position
10.14.2 Shenzhen Weiguang Biological Prophylactic Gamma Globulin Models, Specifications and Application
10.14.3 Shenzhen Weiguang Biological Prophylactic Gamma Globulin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Shenzhen Weiguang Biological Company Profile and Main Business
10.14.5 Shenzhen Weiguang Biological Recent Developments
10.15 CBPO
10.15.1 CBPO Company Information, Head Office, Market Area and Industry Position
10.15.2 CBPO Prophylactic Gamma Globulin Models, Specifications and Application
10.15.3 CBPO Prophylactic Gamma Globulin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.15.4 CBPO Company Profile and Main Business
10.15.5 CBPO Recent Developments
10.16 CNBG
10.16.1 CNBG Company Information, Head Office, Market Area and Industry Position
10.16.2 CNBG Prophylactic Gamma Globulin Models, Specifications and Application
10.16.3 CNBG Prophylactic Gamma Globulin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.16.4 CNBG Company Profile and Main Business
10.16.5 CNBG Recent Developments
10.17 Shanghai RAAS
10.17.1 Shanghai RAAS Company Information, Head Office, Market Area and Industry Position
10.17.2 Shanghai RAAS Prophylactic Gamma Globulin Models, Specifications and Application
10.17.3 Shanghai RAAS Prophylactic Gamma Globulin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.17.4 Shanghai RAAS Company Profile and Main Business
10.17.5 Shanghai RAAS Recent Developments
10.18 Sichuan Yuanda Shuyang
10.18.1 Sichuan Yuanda Shuyang Company Information, Head Office, Market Area and Industry Position
10.18.2 Sichuan Yuanda Shuyang Prophylactic Gamma Globulin Models, Specifications and Application
10.18.3 Sichuan Yuanda Shuyang Prophylactic Gamma Globulin Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.18.4 Sichuan Yuanda Shuyang Company Profile and Main Business
10.18.5 Sichuan Yuanda Shuyang Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Prophylactic Gamma Globulin Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Prophylactic Gamma Globulin Market Restraints
Table 3. Prophylactic Gamma Globulin Market Trends
Table 4. Prophylactic Gamma Globulin Industry Policy
Table 5. Global Prophylactic Gamma Globulin Revenue by Company, 2018-2023, US$ million
Table 6. Global Prophylactic Gamma Globulin Revenue Market Share by Company, 2018-2023
Table 7. Global Prophylactic Gamma Globulin Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Prophylactic Gamma Globulin Sales Volume Market Share by Company, 2018-2023
Table 9. Global Prophylactic Gamma Globulin Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Prophylactic Gamma Globulin Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Prophylactic Gamma Globulin Mergers & Acquisitions, Expansion Plans
Table 12. Global Prophylactic Gamma Globulin Manufacturers Product Type
Table 13. China Prophylactic Gamma Globulin Revenue by Company, 2018-2023, US$ million
Table 14. China Prophylactic Gamma Globulin Revenue Market Share by Company, 2018-2023
Table 15. China Prophylactic Gamma Globulin Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Prophylactic Gamma Globulin Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Prophylactic Gamma Globulin Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Prophylactic Gamma Globulin Import & Export Trends
Table 19. Main Sources of China Prophylactic Gamma Globulin Import
Table 20. Export Destination of China Prophylactic Gamma Globulin
Table 21. Global Headquarters and Manufacturing Base of Prophylactic Gamma Globulin Manufacturers
Table 22. Global Major Manufacturers, Prophylactic Gamma Globulin Capacity Expansion and Future Plans
Table 23. Global Prophylactic Gamma Globulin Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Prophylactic Gamma Globulin Production by Region, 2018-2023, (K Units)
Table 25. Global Prophylactic Gamma Globulin Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Prophylactic Gamma Globulin Upstream (Raw Materials)
Table 27. Global Prophylactic Gamma Globulin Typical Customers
Table 28. Prophylactic Gamma Globulin Typical Distributors
Table 29. By Type, Global Prophylactic Gamma Globulin Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Prophylactic Gamma Globulin Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Prophylactic Gamma Globulin Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Prophylactic Gamma Globulin Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Prophylactic Gamma Globulin Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Prophylactic Gamma Globulin Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Prophylactic Gamma Globulin Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Prophylactic Gamma Globulin Revenue Market Share, 2018-2029
Table 37. By Country, Global Prophylactic Gamma Globulin Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Prophylactic Gamma Globulin Sales Volume Market Share, 2018-2029
Table 39. Baxter Company Information, Head Office, Market Area and Industry Position
Table 40. Baxter Prophylactic Gamma Globulin Models, Specifications and Application
Table 41. Baxter Prophylactic Gamma Globulin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Baxter Company Profile and Main Business
Table 43. Baxter Recent Developments
Table 44. Grifols Company Information, Head Office, Market Area and Industry Position
Table 45. Grifols Prophylactic Gamma Globulin Models, Specifications and Application
Table 46. Grifols Prophylactic Gamma Globulin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Grifols Company Profile and Main Business
Table 48. Grifols Recent Developments
Table 49. Octapharma Company Information, Head Office, Market Area and Industry Position
Table 50. Octapharma Prophylactic Gamma Globulin Models, Specifications and Application
Table 51. Octapharma Prophylactic Gamma Globulin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Octapharma Company Profile and Main Business
Table 53. Octapharma Recent Developments
Table 54. Biotest Company Information, Head Office, Market Area and Industry Position
Table 55. Biotest Prophylactic Gamma Globulin Models, Specifications and Application
Table 56. Biotest Prophylactic Gamma Globulin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Biotest Company Profile and Main Business
Table 58. Biotest Recent Developments
Table 59. Kedrion Biopharma Company Information, Head Office, Market Area and Industry Position
Table 60. Kedrion Biopharma Prophylactic Gamma Globulin Models, Specifications and Application
Table 61. Kedrion Biopharma Prophylactic Gamma Globulin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Kedrion Biopharma Company Profile and Main Business
Table 63. Kedrion Biopharma Recent Developments
Table 64. Takeda Company Information, Head Office, Market Area and Industry Position
Table 65. Takeda Prophylactic Gamma Globulin Models, Specifications and Application
Table 66. Takeda Prophylactic Gamma Globulin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Takeda Company Profile and Main Business
Table 68. Takeda Recent Developments
Table 69. ADMA Biologics Company Information, Head Office, Market Area and Industry Position
Table 70. ADMA Biologics Prophylactic Gamma Globulin Models, Specifications and Application
Table 71. ADMA Biologics Prophylactic Gamma Globulin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. ADMA Biologics Company Profile and Main Business
Table 73. ADMA Biologics Recent Developments
Table 74. BPL Company Information, Head Office, Market Area and Industry Position
Table 75. BPL Prophylactic Gamma Globulin Models, Specifications and Application
Table 76. BPL Prophylactic Gamma Globulin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. BPL Company Profile and Main Business
Table 78. BPL Recent Developments
Table 79. LFB Group Company Information, Head Office, Market Area and Industry Position
Table 80. LFB Group Prophylactic Gamma Globulin Models, Specifications and Application
Table 81. LFB Group Prophylactic Gamma Globulin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. LFB Group Company Profile and Main Business
Table 83. LFB Group Recent Developments
Table 84. Hualan Biological Company Information, Head Office, Market Area and Industry Position
Table 85. Hualan Biological Prophylactic Gamma Globulin Models, Specifications and Application
Table 86. Hualan Biological Prophylactic Gamma Globulin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Hualan Biological Company Profile and Main Business
Table 88. Hualan Biological Recent Developments
Table 89. Beijing Tiantan Biological Company Information, Head Office, Market Area and Industry Position
Table 90. Beijing Tiantan Biological Prophylactic Gamma Globulin Models, Specifications and Application
Table 91. Beijing Tiantan Biological Prophylactic Gamma Globulin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Beijing Tiantan Biological Company Profile and Main Business
Table 93. Beijing Tiantan Biological Recent Developments
Table 94. Beijing Bohui Innovation Biotechnology Company Information, Head Office, Market Area and Industry Position
Table 95. Beijing Bohui Innovation Biotechnology Prophylactic Gamma Globulin Models, Specifications and Application
Table 96. Beijing Bohui Innovation Biotechnology Prophylactic Gamma Globulin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Beijing Bohui Innovation Biotechnology Company Profile and Main Business
Table 98. Beijing Bohui Innovation Biotechnology Recent Developments
Table 99. Pacific Shuanglin Bio-pharmacy Company Information, Head Office, Market Area and Industry Position
Table 100. Pacific Shuanglin Bio-pharmacy Prophylactic Gamma Globulin Models, Specifications and Application
Table 101. Pacific Shuanglin Bio-pharmacy Prophylactic Gamma Globulin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Pacific Shuanglin Bio-pharmacy Company Profile and Main Business
Table 103. Pacific Shuanglin Bio-pharmacy Recent Developments
Table 104. Shenzhen Weiguang Biological Company Information, Head Office, Market Area and Industry Position
Table 105. Shenzhen Weiguang Biological Prophylactic Gamma Globulin Models, Specifications and Application
Table 106. Shenzhen Weiguang Biological Prophylactic Gamma Globulin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Shenzhen Weiguang Biological Company Profile and Main Business
Table 108. Shenzhen Weiguang Biological Recent Developments
Table 109. CBPO Company Information, Head Office, Market Area and Industry Position
Table 110. CBPO Prophylactic Gamma Globulin Models, Specifications and Application
Table 111. CBPO Prophylactic Gamma Globulin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. CBPO Company Profile and Main Business
Table 113. CBPO Recent Developments
Table 114. CNBG Company Information, Head Office, Market Area and Industry Position
Table 115. CNBG Prophylactic Gamma Globulin Models, Specifications and Application
Table 116. CNBG Prophylactic Gamma Globulin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 117. CNBG Company Profile and Main Business
Table 118. CNBG Recent Developments
Table 119. Shanghai RAAS Company Information, Head Office, Market Area and Industry Position
Table 120. Shanghai RAAS Prophylactic Gamma Globulin Models, Specifications and Application
Table 121. Shanghai RAAS Prophylactic Gamma Globulin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 122. Shanghai RAAS Company Profile and Main Business
Table 123. Shanghai RAAS Recent Developments
Table 124. Sichuan Yuanda Shuyang Company Information, Head Office, Market Area and Industry Position
Table 125. Sichuan Yuanda Shuyang Prophylactic Gamma Globulin Models, Specifications and Application
Table 126. Sichuan Yuanda Shuyang Prophylactic Gamma Globulin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 127. Sichuan Yuanda Shuyang Company Profile and Main Business
Table 128. Sichuan Yuanda Shuyang Recent Developments
List of Figure
Figure 1. Prophylactic Gamma Globulin Picture
Figure 2. By Revenue, Global Prophylactic Gamma Globulin Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Prophylactic Gamma Globulin Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Prophylactic Gamma Globulin Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Prophylactic Gamma Globulin Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Prophylactic Gamma Globulin Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Prophylactic Gamma Globulin Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Prophylactic Gamma Globulin Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Prophylactic Gamma Globulin Share of Global Market, 2018-2029
Figure 10. Global Prophylactic Gamma Globulin Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Prophylactic Gamma Globulin Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Prophylactic Gamma Globulin Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Prophylactic Gamma Globulin Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Prophylactic Gamma Globulin Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Prophylactic Gamma Globulin Domestic VS Export, 2022
Figure 16. Global Prophylactic Gamma Globulin Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Prophylactic Gamma Globulin Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Prophylactic Gamma Globulin Production Market Share & Forecast by Region, 2018-2029
Figure 19. Prophylactic Gamma Globulin Industry Chain
Figure 20. Prophylactic Gamma Globulin Procurement Model
Figure 21. Prophylactic Gamma Globulin Sales Model
Figure 22. Prophylactic Gamma Globulin Sales Channels, Direct Sales and Distribution
Figure 23. IVIg Liquid
Figure 24. IVIg Powder
Figure 25. By Type, Global Prophylactic Gamma Globulin Revenue, 2018-2029, US$ Million
Figure 26. By Type, Global Prophylactic Gamma Globulin Revenue Market Share, 2018-2029
Figure 27. By Type, Global Prophylactic Gamma Globulin Sales Volume, 2018-2029, (K Units)
Figure 28. By Type, Global Prophylactic Gamma Globulin Sales Volume Market Share, 2018-2029
Figure 29. By Type, Global Prophylactic Gamma Globulin Price, 2018-2029, (US$/Unit)
Figure 30. Immunodeficiency
Figure 31. Autoimmune Disease
Figure 32. Acute Infection
Figure 33. By Application, Global Prophy
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|